Thuy Tran

2.8k total citations · 1 hit paper
21 papers, 1.9k citations indexed

About

Thuy Tran is a scholar working on Molecular Biology, Computational Theory and Mathematics and Hematology. According to data from OpenAlex, Thuy Tran has authored 21 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Computational Theory and Mathematics and 4 papers in Hematology. Recurrent topics in Thuy Tran's work include Computational Drug Discovery Methods (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Platelet Disorders and Treatments (3 papers). Thuy Tran is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Platelet Disorders and Treatments (3 papers). Thuy Tran collaborates with scholars based in United States and United Kingdom. Thuy Tran's co-authors include Bryan L. Roth, Atheir I. Abbas, Vincent Setola, Brian K. Shoichet, Jérôme Hert, Michael J. Keiser, Christian Laggner, Richard A. Glennon, Sandra J. Hufeisen and John J. Irwin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Thuy Tran

21 papers receiving 1.8k citations

Hit Papers

Predicting new molecular targets for known drugs 2009 2026 2014 2020 2009 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thuy Tran United States 13 1.1k 879 324 276 268 21 1.9k
Kelan Thomas United States 12 920 0.8× 831 0.9× 303 0.9× 239 0.9× 206 0.8× 26 1.8k
Jérôme Hert Switzerland 18 1.9k 1.8× 2.0k 2.3× 488 1.5× 172 0.6× 319 1.2× 23 2.9k
Sandra J. Hufeisen United States 13 1.7k 1.6× 904 1.0× 601 1.9× 1.1k 3.8× 263 1.0× 16 3.4k
Travis T. Wager United States 29 1.7k 1.5× 932 1.1× 484 1.5× 545 2.0× 437 1.6× 42 3.9k
Christian Laggner Austria 31 2.6k 2.4× 1.8k 2.0× 663 2.0× 343 1.2× 447 1.7× 56 4.1k
Richard E. Higgs United States 29 1.3k 1.2× 424 0.5× 357 1.1× 309 1.1× 87 0.3× 70 3.0k
Jacques Hamon Switzerland 16 1.7k 1.5× 1.6k 1.8× 406 1.3× 151 0.5× 533 2.0× 25 3.0k
Philippe Vayer France 19 521 0.5× 451 0.5× 127 0.4× 476 1.7× 112 0.4× 28 1.4k
Michael J. Keiser United States 25 3.3k 3.1× 3.1k 3.5× 886 2.7× 335 1.2× 705 2.6× 51 5.5k
Anabella Villalobos United States 17 1.1k 1.1× 627 0.7× 542 1.7× 381 1.4× 141 0.5× 25 2.3k

Countries citing papers authored by Thuy Tran

Since Specialization
Citations

This map shows the geographic impact of Thuy Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thuy Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thuy Tran more than expected).

Fields of papers citing papers by Thuy Tran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thuy Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thuy Tran. The network helps show where Thuy Tran may publish in the future.

Co-authorship network of co-authors of Thuy Tran

This figure shows the co-authorship network connecting the top 25 collaborators of Thuy Tran. A scholar is included among the top collaborators of Thuy Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thuy Tran. Thuy Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rim, Matthew H, et al.. (2025). Recent and anticipated novel drug approvals (3Q 2025 through 2Q 2026). American Journal of Health-System Pharmacy. 83(1). e19–e26. 1 indexed citations
2.
Tran, Thuy, et al.. (2023). Real-world Experience of Caplacizumab for Adolescents in the First-line Setting: Case Reports. Journal of Pediatric Hematology/Oncology. 45(8). e1031–e1034. 2 indexed citations
3.
Tran, Thuy, et al.. (2022). Avatrombopag for the Treatment of Immune Thrombocytopenia and Periprocedural Thrombocytopenia Associated With Chronic Liver Disease. Journal of Pharmacy Practice. 37(1). 184–189. 3 indexed citations
4.
Arnall, Justin, et al.. (2021). Comparative Utilization and Efficacy of Thrombopoietin Receptor Agonists in Relapsed/Refractory Immune Thrombocytopenia. American Journal of Therapeutics. 28(5). e525–e530. 2 indexed citations
5.
Tran, Thuy, et al.. (2020). Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience. Journal of Thrombosis and Thrombolysis. 49(3). 431–440. 10 indexed citations
6.
Barr, John, Thuy Tran, Brooke M. Rock, Jan L. Wahlstrom, & Upendra P. Dahal. (2020). Strain-Dependent Variability of Early Discovery Small Molecule Pharmacokinetics in Mice: Does Strain Matter?. Drug Metabolism and Disposition. 48(8). 613–621. 18 indexed citations
7.
Barr, John, et al.. (2019). Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species Surrogate. Drug Metabolism and Disposition. 47(4). 419–423. 12 indexed citations
8.
Bui, Minna, Xiaolin Hao, Youngsook Shin, et al.. (2015). Synthesis and SAR study of potent and selective PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(5). 1104–1109. 18 indexed citations
9.
Generaux, Grant T., et al.. (2013). Impact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development. Drug Metabolism and Disposition. 41(12). 1994–2003. 29 indexed citations
10.
Chen, Huifen, Bryan Chan, Jason Drummond, et al.. (2012). Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling. Journal of Medicinal Chemistry. 55(11). 5536–5545. 60 indexed citations
11.
Henne, Kirk R., Thuy Tran, Brooke M. VandenBrink, et al.. (2012). Sequential Metabolism of AMG 487, a Novel CXCR3 Antagonist, Results in Formation of Quinone Reactive Metabolites That Covalently Modify CYP3A4 Cys239 and Cause Time-Dependent Inhibition of the Enzyme. Drug Metabolism and Disposition. 40(7). 1429–1440. 31 indexed citations
12.
Frankowski, Kevin J., Partha Ghosh, Vincent Setola, et al.. (2010). N-Alkyl-octahydroisoquinolin-1-one-8-carboxamides: Selective and Nonbasic κ-Opioid Receptor Ligands. ACS Medicinal Chemistry Letters. 1(5). 189–193. 23 indexed citations
13.
Keiser, Michael J., Vincent Setola, John J. Irwin, et al.. (2009). Predicting new molecular targets for known drugs. Nature. 462(7270). 175–181. 1251 indexed citations breakdown →
14.
Wang, Yonghui, Chaya Duraiswami, Kevin P. Madauss, et al.. (2009). 2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2′,3′:4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 4916–4919. 11 indexed citations
15.
Abbas, Atheir I., Peter B. Hedlund, Xi‐Ping Huang, et al.. (2009). Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology. 205(1). 119–128. 234 indexed citations
16.
Fitch, William L., et al.. (2009). Revisiting the Metabolism of Ketoconazole Using Accurate Mass. Drug Metabolism Letters. 3(3). 191–198. 34 indexed citations
17.
Kumar, Sameer, E. Burton Swanson, & Thuy Tran. (2009). RFID in the healthcare supply chain: usage and application. International Journal of Health Care Quality Assurance. 22(1). 67–81. 75 indexed citations
18.
Madauss, Kevin P., William Burkhart, Thomas G. Consler, et al.. (2009). The human ACC2 CT-domain C-terminus is required for full functionality and has a novel twist. Acta Crystallographica Section D Biological Crystallography. 65(5). 449–461. 25 indexed citations
19.
Washburn, David G., Tram H. Hoang, James S. Frazee, et al.. (2009). Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4664–4668. 7 indexed citations
20.
Biggadike, Keith, Randy K. Bledsoe, Dan Coe, et al.. (2009). Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor. Proceedings of the National Academy of Sciences. 106(43). 18114–18119. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026